Oh, and who should be doing the research? The way it’s usually done is that an independent monitoring group is contracted as a go-between. They monitor the involved study sites that are carrying out the research, and collect the data, making sure it is “de-identified” and “blinded” before going to the company, so that the company does not know which study participant got which treatment. The data is analyzed, looking for differences in response to treatment, frequency/severity of problems/side effects, and so on. Only after this is the treatment type revealed.
Really, you wouldn’t believe how many cases I’ve seen where treatments were thought or hoped to work, and only later it turned out they didn’t. The majority of medical research starts out with animal testing to look for anything glaringly wrong in terms of safety, then is tested in healthy humans to again check for overall safety. Then the treatment is tested by itself, under a controlled study with all side effects closely monitored and noted, and finally if that seems to work, it goes on to a test versus a placebo, often with another treatment being used at the same time in both groups (or as a “rescue” backup only) to see if the new treatment helps even more.
The last phase (called phase III testing) is where things tend to not work out so well, where researchers find out that it’s not any better than placebo, or that the side effects are so awful that - unless the disease is fatal or something and there are few other options - the treatment is not considered worth the risk.
Here’s one example. I was working at my current workplace, but not directly on the study in question. It was for a treatment (that also involved surgery in the process) that was hoped to help give back at least a little bit of light/dark perception and maybe more, in a particular disease that pretty much inevitably led to blindness, and there were no effective treatments out there. As you might guess, there was a lot of excitement about it. A doctor had come up with the idea originally, and raised money to test it. First it was tested on a small number of people with the disease and some encouraging positive results were seen, possibly some improved light/dark perception and similar things, so a new study (testing it versus placebo) was done at various hospitals. It was also talked about on one of those “new medical miracles” shows on the Discovery Channel or something like that, and I think it’s from there that it went crazy - somehow it got picked up by a big radio show (the sponsor of the study wasn’t involved in this; we think it was maybe an excited participant from the first study) and the host hyped it as being a miracle cure for this incurable disease, and talked about where the study was being done. Meanwhile I come into work on Monday and boom, all of our office’s voicemails are full with messages from all over the US and the world. It was crazy! People were begging to get into this closed study, and all we could do is refer them to the company to get on a waiting list for the next study. It was years ago that this happened and I still get calls to this day asking about the treatment.
What happened? The people who’d actually received the treatment didn’t do any better than placebo. In fact, none of them did that well at all in the long run, and with more people involved, they were better able to see various side effects - sometimes side effects are so rare that they might show up only 1 in 1,000 cases, 1 in 10,000, etc. No miracle cure, not even a passable treatment.
Listen, I don’t have a dog in this fight, or if I do, it’s actually on your side. When I was a little kid, I had an aunt with MS. My sister had a MS scare herself, with some possible brain lesions turning up that had her nervous until it was ruled out, and I understand what a nasty bitch of a disease this is. I’m just talking about how research is done in the US and around the world. Surgical treatments are put through rigorous testing every day; it’s not something that’s done only for medications. It would be a benefit to those affected by MS if this could be similarly tested.